Medicienna Healthcare's exclusive regional distribution relationship with Pharco Pharmaceuticals, Egypt, provides the foundation for extending access to Baraka 450mg in Malaysia and selected international markets.
Baraka was officially reintroduced in Malaysia on 17 July 2025 through collaboration involving Pharco Pharmaceuticals, Medicienna Healthcare, IED Healthcare, and Essentiq Pharma.
Together with IED Direct, this collaboration ecosystem supports responsible market development and practical access to the product. Each organisation contributes to a broader network connecting the original Egyptian manufacturer with healthcare and distribution capabilities in destination markets.
The next stage centres on Indonesia as a major ASEAN opportunity while developing pathways for wider international reach, including the United Kingdom.